Clinical trials
Observational Recurrence trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 4 |
| AbbVie | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Amsterdam UMC, location VUmc | 1 |
| AstraZeneca | 1 |
| Biogen | 1 |
| Celgene | 1 |
| Erasmus Medical Center | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Mark C Burgmans, MD PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 16 |
| Neoplasm Metastasis | 5 |
| Carcinoma, Squamous Cell | 2 |
| Colorectal Neoplasms | 2 |
| Cutaneous Squamous Cell Carcinoma | 2 |
| Disease | 2 |
| Kidney Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Skin Neoplasms | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.